Priveq invests in Carmel Pharma

By 07/05/2009No Comments

Priveq Investment becomes one of the new main owners of Carmel Pharma AB, a world leader in closed drug transfer systems for handling of hazardous drugs, such as cytostatics. Other main shareholders are Investor Growth Capital, Industrifonden, Start Invest and the company management.

[hr top=”20″ bottom=”20″]
[register_getpdf pdftitle=”Press release” pdflink=””]
[hr top=”20″ bottom=”20″]